Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
Condition(s):Recurrent Ovarian CancerLast Updated:October 6, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Recurrent Ovarian CancerLast Updated:October 6, 2023Not yet recruiting
Condition(s):Recurrent Ovarian CancerLast Updated:December 22, 2023Not yet recruiting
Condition(s):Platinum-resistant Recurrent Ovarian CancerLast Updated:January 22, 2021Unknown status
Condition(s):Ovarian Epithelial Cancer RecurrentLast Updated:March 27, 2020Completed
Condition(s):Recurrent Ovarian CancerLast Updated:March 13, 2024Not yet recruiting
Condition(s):Recurrent Ovarian CancerLast Updated:August 7, 2018Unknown status
Condition(s):Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorLast Updated:July 12, 2021Recruiting
Condition(s):Recurrent Ovarian CancerLast Updated:January 19, 2024Recruiting
Condition(s):Ovarian Cancer RecurrentLast Updated:June 7, 2023Withdrawn
Condition(s):Recurrent Ovarian CancerLast Updated:August 14, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.